Novel Autotaxin Inhibitor for the Treatment of Idiopathic Pulmonary Fibrosis: A Clinical Candidate Discovered Using DNA-Encoded Chemistry

被引:87
作者
Cuozzo, John W. [1 ]
Clark, Matthew A. [1 ]
Keefe, Anthony D. [1 ]
Kohlmann, Anna [1 ]
Mulvihill, Mark [2 ]
Ni, Haihong [3 ]
Renzetti, Louis M. [2 ]
Resnicow, Daniel, I [1 ]
Ruebsam, Frank [3 ]
Sigel, Eric A. [1 ]
Thomson, Heather A. [1 ]
Wang, Ce [3 ]
Xie, Zhifeng [3 ]
Zhang, Ying [1 ]
机构
[1] XChem Inc, Waltham, MA 02543 USA
[2] XRx Inc, New York, NY 10016 USA
[3] BioDuro LLC, Beijing 102206, Peoples R China
关键词
ENZYME;
D O I
10.1021/acs.jmedchem.0c00688
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The activity of the secreted phosphodiesterase autotaxin produces the inflammatory signaling molecule LPA and has been associated with a number of human diseases including idiopathic pulmonary fibrosis (IPF). We screened a single DNA-encoded chemical library (DECL) of 225 million compounds and identified a series of potent inhibitors. Optimization of this series led to the discovery of compound 1 (X-165), a highly potent, selective, and bioavailable small molecule. Cocrystallization of compound 1 with human autotaxin demonstrated that it has a novel binding mode occupying both the hydrophobic pocket and a channel near the autotaxin active site. Compound 1 inhibited the production of LPA in human and mouse plasma at nanomolar levels and showed efficacy in a mouse model of human lung fibrosis. After successfully completing IND-enabling studies, compound 1 was approved by the FDA for a Phase I clinical trial. These results demonstrate that DECL hits can be readily optimized into clinical candidates.
引用
收藏
页码:7840 / 7856
页数:17
相关论文
共 23 条
[1]   Discovering Drugs with DNA-Encoded Library Technology: From Concept to Clinic with an Inhibitor of Soluble Epoxide Hydrolase [J].
Belyanskaya, Svetlana L. ;
Ding, Yun ;
Callahan, James F. ;
Lazaar, Aili L. ;
Israel, David I. .
CHEMBIOCHEM, 2017, 18 (09) :837-842
[2]   Coming of Age for Autotaxin and Lysophosphatidate Signaling: Clinical Applications for Preventing, Detecting and Targeting Tumor-Promoting Inflammation [J].
Benesch, Matthew G. K. ;
MacIntyre, Iain T. K. ;
McMullen, Todd P. W. ;
Brindley, David N. .
CANCERS, 2018, 10 (03)
[3]  
Daccord C., 2016, F1000RES
[4]   Discovery of 2-[[2-Ethyl-6-[4-[2-(3-hydroxyazetidin-1-yl)-2-oxoethyl]piperazin-1-yl]-8-methylimidazo[1,2-a]pyridin-3-yl]methylamino]-4-(4-fluorophenyl)thiazole-5-carbonitrile (GLPG1690), a First-in-Class Autotaxin Inhibitor Undergoing Clinical Evaluation for the Treatment of Idiopathic Pulmonary Fibrosis [J].
Desroy, Nicolas ;
Housseman, Christopher ;
Bock, Xavier ;
Joncour, Agnes ;
Bienvenu, Natacha ;
Cherel, Laetitia ;
Labeguere, Virginie ;
Rondet, Emilie ;
Peixoto, Christophe ;
Grassot, Jean-Marie ;
Picolet, Olivier ;
Annoott, Denis ;
Triballeau, Nicolas ;
Monjardet, Alain ;
Wakselman, Emanuelle ;
Roncoroni, Veronique ;
Le Tallec, Sandrine ;
Blanque, Roland ;
Cottereaux, Celine ;
Vandervoort, Nele ;
Christophe, Thierry ;
Mollat, Patrick ;
Lamers, Marieke ;
Auberval, Marielle ;
Hrvacic, Boska ;
Ralic, Jovica ;
Oste, Line ;
van der Aar, Ellen ;
Brys, Reginald ;
Heckmann, Bertrand .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (09) :3580-3590
[5]   DNA-encoded chemistry: enabling the deeper sampling of chemical space [J].
Goodnow, Robert A., Jr. ;
Dumelin, Christoph E. ;
Keefe, Anthony D. .
NATURE REVIEWS DRUG DISCOVERY, 2017, 16 (02) :131-147
[6]   Lysophosphatidic acid and autotaxin stimulate cell motility of neoplastic and non-neoplastic cells through LPA1 [J].
Hama, K ;
Aoki, J ;
Fukaya, M ;
Kishi, Y ;
Sakai, T ;
Suzuki, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2004, 279 (17) :17634-17639
[7]   Discovery of a First-in-Class Receptor Interacting Protein 1 (RIP1) Kinase Specific Clinical Candidate (GSK2982772) for the Treatment of Inflammatory Diseases [J].
Harris, Philip A. ;
Berger, Scott B. ;
Jeong, Jae U. ;
Nagilla, Rakesh ;
Bandyopadhyay, Deepak ;
Campobasso, Nino ;
Capriotti, Carol A. ;
Cox, Julie A. ;
Dare, Lauren ;
Dong, Xiaoyang ;
Eidam, Patrick M. ;
Finger, Joshua N. ;
Hoffman, Sandra J. ;
Kang, James ;
Kasparcova, Viera ;
King, Bryan W. ;
Lehr, Ruth ;
Lan, Yunfeng ;
Leister, Lara K. ;
Lich, John D. ;
MacDonald, Thomas T. ;
Miller, Nathan A. ;
Ouellette, Michael T. ;
Pao, Christina S. ;
Rahman, Attiq ;
Reilly, Michael A. ;
Rendina, Alan R. ;
Rivera, Elizabeth J. ;
Schaeffer, Michelle C. ;
Sehon, Clark A. ;
Singhaus, Robert R. ;
Sun, Helen H. ;
Swift, Barbara A. ;
Totoritis, Rachel D. ;
Vossenkaemper, Anna ;
Ward, Paris ;
Wisnoski, David D. ;
Zhang, Daohua ;
Marquis, Robert W. ;
Gough, Peter J. ;
Bertin, John .
JOURNAL OF MEDICINAL CHEMISTRY, 2017, 60 (04) :1247-1261
[8]   DNA-Encoded Library Screening Identifies Benzo[b][1,4]oxazepin-4-ones as Highly Potent and Monoselective Receptor Interacting Protein 1 Kinase Inhibitors [J].
Harris, Philip A. ;
King, Bryan W. ;
Bandyopadhyay, Deepak ;
Berger, Scott B. ;
Campobasso, Nino ;
Capriotti, Carol A. ;
Cox, Julie A. ;
Dare, Lauren ;
Dong, Xiaoyang ;
Finger, Joshua N. ;
Grady, LaShadric C. ;
Hoffmann, Sandra J. ;
Jeong, Jae U. ;
Kang, James ;
Kasparcova, Viera ;
Lakdawala, Ami S. ;
Lehr, Ruth ;
McNulty, Dean E. ;
Nagilla, Rakesh ;
Ouellette, Michael T. ;
Pao, Christina S. ;
Rendina, Alan R. ;
Schaeffer, Michelle C. ;
Summerfield, Jennifer D. ;
Swift, Barbara A. ;
Totoritis, Rachel D. ;
Ward, Paris ;
Zhang, Aming ;
Zhang, Daohua ;
Marquis, Robert W. ;
Bertin, John ;
Gough, Peter J. .
JOURNAL OF MEDICINAL CHEMISTRY, 2016, 59 (05) :2163-2178
[9]   Autotaxin in liver fibrosis [J].
Ikeda, Hitoshi ;
Yatomi, Yutaka .
CLINICA CHIMICA ACTA, 2012, 413 (23-24) :1817-1821
[10]   Novel Autotaxin Inhibitors for the Treatment of Osteoarthritis Pain: Lead Optimization via Structure-Based Drug Design [J].
Jones, Spencer B. ;
Pfeifer, Lance A. ;
Bleisch, Thomas J. ;
Beauchamp, Thomas J. ;
Durbin, Jim D. ;
Klimkowski, V. Joseph ;
Hughes, Norman E. ;
Rito, Christopher J. ;
Dao, Yen ;
Gruber, Joseph M. ;
Bui, Hai ;
Chambers, Mark G. ;
Chandrasekhar, Srinivasan ;
Lin, Chaohua ;
McCann, Denis J. ;
Mudra, Daniel R. ;
Oskins, Jennifer L. ;
Swearingen, Craig A. ;
Thirunavukkarasu, Kannan ;
Norman, Bryan H. .
ACS MEDICINAL CHEMISTRY LETTERS, 2016, 7 (09) :857-861